These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 15878101)
41. Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases. Chow E; Ling A; Davis L; Panzarella T; Danjoux C Radiother Oncol; 2005 Apr; 75(1):64-9. PubMed ID: 15878102 [TBL] [Abstract][Full Text] [Related]
42. Effectiveness and prognostic factors of radiotherapy for painful plantar heel spurs. Schneider O; Stückle CA; Bosch E; Gott C; Adamietz IA Strahlenther Onkol; 2004 Aug; 180(8):502-9. PubMed ID: 15292971 [TBL] [Abstract][Full Text] [Related]
43. Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial. Sande TA; Ruenes R; Lund JA; Bruland OS; Hornslien K; Bremnes R; Kaasa S Radiother Oncol; 2009 May; 91(2):261-6. PubMed ID: 19307034 [TBL] [Abstract][Full Text] [Related]
44. Radiotherapy for painful bone metastases from hepatocellular carcinoma. Seong J; Koom WS; Park HC Liver Int; 2005 Apr; 25(2):261-5. PubMed ID: 15780048 [TBL] [Abstract][Full Text] [Related]
46. [Radiotherapy for bone metastases from hepatocellular carcinoma and pancreas cancer]. Harada H; Nishimura T; Kamata M; Asakura H; Zenda S; Takahashi M; Katagiri H; Takagi T Gan To Kagaku Ryoho; 2006 Aug; 33(8):1061-4. PubMed ID: 16912522 [TBL] [Abstract][Full Text] [Related]
47. Palliative radiation therapy of symptomatic recurrent bladder cancer. Yi SK; Yoder M; Zaner K; Hirsch AE Pain Physician; 2007 Mar; 10(2):285-90. PubMed ID: 17387350 [TBL] [Abstract][Full Text] [Related]
48. Is response to radiotherapy in patients related to the severity of pretreatment pain? Kirou-Mauro A; Hird A; Wong J; Sinclair E; Barnes EA; Tsao M; Danjoux C; Chow E Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1208-12. PubMed ID: 18572084 [TBL] [Abstract][Full Text] [Related]
49. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
50. Assessment of the usefulness of hemibody irradiation in painful bone metastasis. Biswal BM J Indian Med Assoc; 2004 Mar; 102(3):133-4, 136-7. PubMed ID: 15473272 [TBL] [Abstract][Full Text] [Related]
51. Change in urinary markers of osteoclast activity following palliative radiotherapy for bone metastases. Chow E; Hird A; Zhang L; Sinclair E; Danjoux C; Barnes E; Tsao M; Barbera L; Wong S; Vieth R Clin Oncol (R Coll Radiol); 2009 May; 21(4):336-42. PubMed ID: 19250812 [TBL] [Abstract][Full Text] [Related]
52. Half body irradiation of patients with multiple bone metastases: a phase II trial. Berg RS; Yilmaz MK; Høyer M; Keldsen N; Nielsen OS; Ewertz M Acta Oncol; 2009; 48(4):556-61. PubMed ID: 18979285 [TBL] [Abstract][Full Text] [Related]
53. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary. Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539 [TBL] [Abstract][Full Text] [Related]
54. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Rades D; Veninga T; Stalpers LJ; Schulte R; Hoskin PJ; Poortmans P; Schild SE; Rudat V Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):182-8. PubMed ID: 16198069 [TBL] [Abstract][Full Text] [Related]
55. Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial. Yeoh EE; Holloway RH; Fraser RJ; Botten RJ; Di Matteo AC; Butters J; Weerasinghe S; Abeysinghe P Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1072-83. PubMed ID: 16965866 [TBL] [Abstract][Full Text] [Related]
56. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial. Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E; Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570 [TBL] [Abstract][Full Text] [Related]
57. [Radiation therapy in bone metastases from lung cancer]. Katano S; Hayakawa K; Nakajima N; Nakamura Y; Nakayama Y; Ikeda H; Yamakawa M; Mitsuhashi N; Niibe H Gan No Rinsho; 1989 Nov; 35(14):1627-30. PubMed ID: 2480460 [TBL] [Abstract][Full Text] [Related]
58. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). Bjarnason GA; Mackenzie RG; Nabid A; Hodson ID; El-Sayed S; Grimard L; Brundage M; Wright J; Hay J; Ganguly P; Leong C; Wilson J; Jordan RC; Walker M; Tu D; Parulekar W; Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):166-72. PubMed ID: 18805649 [TBL] [Abstract][Full Text] [Related]
59. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788 [TBL] [Abstract][Full Text] [Related]
60. Single-fraction radiosurgery for the treatment of spinal breast metastases. Gerszten PC; Burton SA; Welch WC; Brufsky AM; Lembersky BC; Ozhasoglu C; Vogel WJ Cancer; 2005 Nov; 104(10):2244-54. PubMed ID: 16216003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]